A Novel Delivery System for the Controlled Release~of Antimicrobial Peptides: Citropin 1.1 and Temporin A

Antimicrobial peptides (AMPs) are prospective therapeutic options for treating multiple-strain infections. However, clinical and commercial development of AMPs has some limitations due to their limited stability, low bioavailability, and potential hemotoxicity. The purpose of this study was to devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Piotrowska, Urszula, Oledzka, Ewa, Zgadzaj, Anna, Bauer, Marta, Sobczak, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415511/
https://www.ncbi.nlm.nih.gov/pubmed/30966523
http://dx.doi.org/10.3390/polym10050489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415511/
https://www.ncbi.nlm.nih.gov/pubmed/30966523
http://dx.doi.org/10.3390/polym10050489

Ejemplares similares